These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 8869671)
21. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure. Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242 [TBL] [Abstract][Full Text] [Related]
22. Clinical study of interaction between rocuronium and some commonly used antimicrobial agents. Cooper R; Maddineni VR; Mirakhur RK Eur J Anaesthesiol; 1993 Sep; 10(5):331-5. PubMed ID: 11767421 [TBL] [Abstract][Full Text] [Related]
23. Variability of duration of action of neuromuscular-blocking drugs in elderly patients. Arain SR; Kern S; Ficke DJ; Ebert TJ Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium. Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539 [TBL] [Abstract][Full Text] [Related]
25. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex. White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792 [TBL] [Abstract][Full Text] [Related]
26. Rocuronium onset of action: a comparison with atracurium and vecuronium. Bartkowski RR; Witkowski TA; Azad S; Lessin J; Marr A Anesth Analg; 1993 Sep; 77(3):574-8. PubMed ID: 8103649 [TBL] [Abstract][Full Text] [Related]
27. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia. Ma H; Zhuang X Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090 [TBL] [Abstract][Full Text] [Related]
28. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block. Lavery GG; Mirakhur RK; Gibson FM Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421 [TBL] [Abstract][Full Text] [Related]
29. Attenuation of a rocuronium-induced neuromuscular block in patients receiving prednisolone. Soltész S; Mencke T; Stunz M; Diefenbach C; Ziegeler S; Molter GP Acta Anaesthesiol Scand; 2009 Apr; 53(4):443-8. PubMed ID: 19317861 [TBL] [Abstract][Full Text] [Related]
30. A comparison of intubation conditions and time-course of action with rocuronium and mivacurium for day case anaesthesia. Pendeville PE; Lois F; Scholtes JL Eur J Anaesthesiol; 2007 Jun; 24(6):546-50. PubMed ID: 17241507 [TBL] [Abstract][Full Text] [Related]
31. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium? Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335 [TBL] [Abstract][Full Text] [Related]
32. Acceleromyography vs. electromyography: an ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation. Kopman AF; Chin W; Cyriac J Acta Anaesthesiol Scand; 2005 Mar; 49(3):316-22. PubMed ID: 15752395 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the onset and intubation conditions of rocuronium bromide. De Mey JC; Debrock M; Rolly G Eur J Anaesthesiol Suppl; 1994; 9():37-40. PubMed ID: 7925206 [TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure. Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664 [TBL] [Abstract][Full Text] [Related]